Twelve-month safety and effectiveness of TCD-17187 drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery.

Osamu Iida Yoshimitsu SogaShu-Ichi SekiDaizo KawasakiHitoshi AnzaiHiroshi AndoTatsuya NakamaNorihiko ShinozakiAmane KozukiMasaharu IshiharaKazushi UrasawaSatoru ToiHiroaki TsujitaKazuki TobitaKenji OgataKazunori Horie Naoki Hayakawa Shinsuke MoriMasahiko FujiharaTakao OhkiKenichiro YubaToshiaki ManoMasato Nakamuranull null

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)

This preapproval trial confirmed the safety and effectiveness of TCD-17187 DCB in the treatment of atherosclerotic lesions in the SFA and/or proximal PA.

Keyphrases

randomized controlled trial
systematic review
clinical trial
emergency department
study protocol
phase iii
smoking cessation
replacement therapy
open label